CAMBRIDGE, Mass., May 2, 2013 /PRNewswire/ -- ETEX Corporation, an advanced biomaterials company, today announced the renewal and long term extension of their Supply Agreement with Knee Creations, LLC.
Knee Creations utilizes ETEX's proprietary nanocrystalline calcium phosphate technology in their novel Subchondroplasty® procedure.
Brian Ennis, President and CEO of ETEX Corporation comments: "ETEX and Knee Creations have forged a dynamic partnership over the past three years. It has been our pleasure to assist Knee Creations in establishing a revolutionary treatment method to address defects associated with chronic bone marrow lesions. ETEX is pleased and excited to extend our collaboration for the long term and we look forward to supporting Knee Creations as they maximize their growth potential."
About ETEX Corporation
Established in 1989, ETEX Corporation develops, manufactures and commercializes calcium phosphate-based biomaterials for improved orthopedic clinical outcomes. A leader in bioresorbable bone substitute materials, ETEX focuses on expanding applications through combinations with cells, biologics, or therapeutic agents delivered in minimally invasive and easy to use systems. For more information, visit www.etexcorp.com.
SOURCE ETEX Corporation